This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Albemarle discipline on costs to continue, says Truist
Truist analyst Peter Osterland keeps a Buy rating and $210 price target on Albemarle (ALB) after the company’s non-deal roadshow. The significant momentum for lithium pricing seen in recent months appears to be sustainable, with strong demand growth particularly driven by the EV and grid storage markets likely to outpace industry supply growth in the near to medium term, the analyst tells investors in a research note. The firm also expects the company’s discipline around costs and capital expenditures to continue near term, Truist adds.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALB:
Disclaimer & DisclosureReport an Issue
- Balanced Risk‑Reward Amid Disciplined Capital Deployment and Limited Near‑Term Upside at Albemarle
- Albemarle Adds Independent Directors to Strengthen Board Governance
- Upstart, Albemarle, Honeywell, Medtronic, Freeport Insiders Act
- Early notable gainers among liquid option names on February 25th
- Early notable gainers among liquid option names on February 24th
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
